Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors.

Joshi PM, Sutor SL, Huntoon CJ, Karnitz LM
J Biol Chem. 2014 Mar 28;289(13):9247-53. doi: 10.1074/jbc.M114.551143. Epub 2014 Feb 19. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.